Medical treatments are already personalised, in that patients are assessed before a suitable treatment is selected for them. But did you know that a large portion of treatments are ineffective being applied to the wrong community of patients? Or that conventional drug therapies currently in use do not take into account individual genetic variations and differences in response to drugs?
Content
COST (European Cooperation in Science and Technology) is one of the longest-running European instruments supporting cooperation among scientists and researchers across Europe. read more
